Amicus in the News

VentureWire (Dow Jones)

Amicus Therapeutics Adds Chief Scientific Officer

January 6, 2006

Amicus Therapeutics named David Lockhart chief scientific officer. Lockhart fills a new position in which he will oversee the existing programs and explore new indications for Amicus' pharmacological chaperone technology. "There's a lot of additional work to do in terms of understanding the basic mechanism of action... and exploring the possibility of broader applications." Lockhart said.

Full story available at http://people.venturewire.com (subscription required)